Drug Database
Back to search

Poland· PL-100219920

Tisseel Lyo

A all other therapeutic products product containing preparat złożony, registered in Poland by Baxter Polska Sp. z o.o.. The same ATC class is registered in 2 of our 19 countries.

ATC V03A

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedTisseel LyoATCV03AREGISTER NO.PL-100219920PACKS LISTED3CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about preparat złożonyAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Preparat złożony is registered in 2 of 19 countries.

Countries holding a registration under ATC V03A (all other therapeutic products), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose
Search preparat złożony products by name

Preparat złożony · ATC V03A

2 / 19 countries

  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Preparat złożony
Manufacturer
Baxter Polska Sp. z o.o.
Country
Poland (PL)
ATC code
V03A
ATC class
ALL OTHER THERAPEUTIC PRODUCTS
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909990747986
  • gtin
    05909990747962
  • gtin
    05909990747979

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under V03A

All other therapeutic products, as other registers publish it.

All preparat złożony products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ebc526e7-9e78-42e6-b598-bf0414d524f4
GET /v1/drugs/ebc526e7-9e78-42e6-b598-bf0414d524f4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek i rozpuszczalnik do przygotowania kleju do tkanek",
  "source": "urpl",
  "strength": "-",
  "packaging": "05909990747962 ¦ Lz ¦ 54829\n1 zestaw  do sporz. 2 ml produktu: 2 fiol. proszku + 2 fiol. rozp. + zestaw do odtwarzania i nakładania (DUPLOJECT)\n05909990747979 ¦ Lz ¦ 54830\n1 zestaw  do sporz. 4 ml produktu: 2 fiol. proszku + 2 fiol. rozp. + zestaw do odtwarzania i nakładania (DUPLOJECT)\n05909990747986 ¦ Lz ¦ 54833\n1 zestaw  do sporz. 10 ml produktu: 2 fiol. proszku + 2 fiol. rozp. + zestaw do odtwarzania i nakładania (DUPLOJECT)",
  "substance": "Aprotininum 3000 KIU (składnik 1) + Calcii chloridum dihydricum 40 mcmol (składnik 2) + Fibrinogenum humanum 91 mg (skłądnik 1) + Trombinum humanum 500 j.m. (składnik 2)",
  "common_name": "Preparat złożony",
  "pl_product_id": "100219920",
  "pozwolenie_nr": "16256",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about preparat złożony.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console